CA2394699C - Device for injection of antiparasitic agents in domestic animals - Google Patents
Device for injection of antiparasitic agents in domestic animals Download PDFInfo
- Publication number
- CA2394699C CA2394699C CA002394699A CA2394699A CA2394699C CA 2394699 C CA2394699 C CA 2394699C CA 002394699 A CA002394699 A CA 002394699A CA 2394699 A CA2394699 A CA 2394699A CA 2394699 C CA2394699 C CA 2394699C
- Authority
- CA
- Canada
- Prior art keywords
- injection
- injection device
- active substance
- antiparasitic
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002347 injection Methods 0.000 title claims abstract description 36
- 239000007924 injection Substances 0.000 title claims abstract description 36
- 241001465754 Metazoa Species 0.000 title claims abstract description 19
- 239000003096 antiparasitic agent Substances 0.000 title claims description 29
- 229940125687 antiparasitic agent Drugs 0.000 title description 5
- 238000009472 formulation Methods 0.000 claims abstract description 31
- 239000000203 mixture Substances 0.000 claims abstract description 31
- 239000013543 active substance Substances 0.000 claims abstract description 16
- 230000002141 anti-parasite Effects 0.000 claims description 24
- 210000003491 skin Anatomy 0.000 claims description 18
- 210000002615 epidermis Anatomy 0.000 claims description 3
- 210000003205 muscle Anatomy 0.000 claims description 3
- FSVJFNAIGNNGKK-UHFFFAOYSA-N 2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one Chemical compound C1C(C2=CC=CC=C2CC2)N2C(=O)CN1C(=O)C1CCCCC1 FSVJFNAIGNNGKK-UHFFFAOYSA-N 0.000 claims description 2
- 229920002101 Chitin Polymers 0.000 claims description 2
- 240000004460 Tanacetum coccineum Species 0.000 claims description 2
- ROVGZAWFACYCSP-MQBLHHJJSA-N [2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(C\C=C/C=C)C(=O)C1 ROVGZAWFACYCSP-MQBLHHJJSA-N 0.000 claims description 2
- 150000001556 benzimidazoles Chemical class 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 150000004657 carbamic acid derivatives Chemical class 0.000 claims description 2
- 239000003112 inhibitor Substances 0.000 claims description 2
- 150000002990 phenothiazines Chemical class 0.000 claims description 2
- 150000003014 phosphoric acid esters Chemical class 0.000 claims description 2
- 229960002957 praziquantel Drugs 0.000 claims description 2
- 229940015367 pyrethrum Drugs 0.000 claims description 2
- 210000004003 subcutaneous fat Anatomy 0.000 claims description 2
- 238000003786 synthesis reaction Methods 0.000 claims description 2
- 239000000126 substance Substances 0.000 description 16
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000035515 penetration Effects 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 235000011837 pasties Nutrition 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 231100000987 absorbed dose Toxicity 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000012907 medicinal substance Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/46—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for controlling depth of insertion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31525—Dosing
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Fodder In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Catching Or Destruction (AREA)
Abstract
The invention relates to an apparatus for injecting an active substance formulation in domestic animals, in which the apparatus comprises an injection device designed in such a way that the hypodermic needle penetrates the upper, but not the lower skin layers, and an active substance formulation with an antiparasitically active substance in a formulation suitable for injection purposes.
Description
DEVICE FOR INJECTION OF ANTIPARASITIC AGENTS IN DOMESTIC
ANIMALS
The invention relates to an apparatus for the application or administration of antiparasitic substances to domestic animals. The invention more particularly relates to an injection device for injectable, antiparasitically acting medicinal substances enabling the latter to be applied intradermally.
EP 897 728 Al discloses an injection device in the form of a pin, with which an adjustable liquid quantity present in a storage container in the pin, is removed from the latter by moving a pushbutton in the longitudinal direction of the pin and can be injected into a living being through a cannula. The disclosure more particularly deals with a reliable retention of the storage container, e.g. a medicament phial, and the construction of the adjustable dosing device.
U.S. Patent 5,964,731 discloses a retention support for a lancet or hypodermic needle, which makes it possible for the part appropriate for perforation to project from a sleeve and then be retracted into the sleeve again after use.
In addition, the part suitable for perforation is covered in the retracted position by a cover located within the sleeve. According to this disclosure the cover, which is inverted over the needle or lancet retracted into the sleeve after use, is designed in such a way that said process is irreversible and the device cannot be used a second time.
WO 99/27984 discloses an injection device for medical use with which in particular pasty fluids can be pressed by means of an electric drive out of the storage cylinder by a plunger and can be supplied to a hypodermic needle.
Known injection devices are suitable for the injection of liquid or pasty medicinal substance formulations, the dose being adjustable or can be fixed by the construction. In each case disclosed lengths of the hypodermic needles are suitable for intramuscular or intravenous injection. As opposed to this, the present invention proposes a planned injection of the substance formulation in specific skin layers directly below the skin surface of the animal.
Antiparasitic substances are administered either orally/intramuscularly to animals, or are applied externally to the skin. Externally applied, antiparasitic substances can diffuse through the skin layers of the animal and are subsequently systemically distributed within the animal, provided that they have a relatively low molecular weight, are sufficiently lypophilic and are applied in a formulation with permeation-increasing substances, such as e.g. 2-dimethyl sulphoxide, 2-pyrrolidone, ethanol, urea, etc. as absorption providing agents.
A disadvantage of external application is that the antiparasitic substance must be formulated with a large proportion of absorption providing agent in order to render the diffusion barrier of the skin permeable for the active substance.
As a result the natural skin function is destroyed. In addition, in the case of external application, the formulation must be used in excess, because only a proportion of the antiparasitic substance applied actually diffuses through the skin and the remaining part is passed into the environment as a pollutant without having any effect on the animal.
The essential factors influencing the proportion of the applied, antiparasitic formulation diffusing into the skin layer are the specific state of the treated skin region, i.e. the specific characteristics of a particular body area, the age and moistness of the skin and the individually differing characteristics of the skin. It is therefore difficult to estimate for a particular animal the quantity of the antiparasitic formulation necessary for obtaining the appropriately absorbed dose of the antiparasitic substance.
In view of this prior art, the present invention provides an apparatus enabling an antiparasitic substance to be administered to an animal in a reliably constant or adjustable dosage.
According to an aspect of the present invention, there is provided a combination consisting of a device for the injection of an active substance formulation into domestic animals and an active substance formulation having an antiparasitically active substance in a formulation suitable for injection, wherein the device is an injection device comprising an injection needle adapted for penetration through the outer epidermis of skin and is positioned between the outer epidermis and the lower layer of the skin above subcutaneous fat and muscle tissue and wherein the antiparasitic active substance is selected from the group consisting of IGR
chitin synthesis inhibitors, phosphoric acid esters, carbamates, pyrethrum and pyrethoids, avermectine, benzimidazoles, phenothiazines or praziquantel.
The solution provided by the invention is to offer a combination of an injection device with an antiparasitic substance in a formulation suitable for injection.
ANIMALS
The invention relates to an apparatus for the application or administration of antiparasitic substances to domestic animals. The invention more particularly relates to an injection device for injectable, antiparasitically acting medicinal substances enabling the latter to be applied intradermally.
EP 897 728 Al discloses an injection device in the form of a pin, with which an adjustable liquid quantity present in a storage container in the pin, is removed from the latter by moving a pushbutton in the longitudinal direction of the pin and can be injected into a living being through a cannula. The disclosure more particularly deals with a reliable retention of the storage container, e.g. a medicament phial, and the construction of the adjustable dosing device.
U.S. Patent 5,964,731 discloses a retention support for a lancet or hypodermic needle, which makes it possible for the part appropriate for perforation to project from a sleeve and then be retracted into the sleeve again after use.
In addition, the part suitable for perforation is covered in the retracted position by a cover located within the sleeve. According to this disclosure the cover, which is inverted over the needle or lancet retracted into the sleeve after use, is designed in such a way that said process is irreversible and the device cannot be used a second time.
WO 99/27984 discloses an injection device for medical use with which in particular pasty fluids can be pressed by means of an electric drive out of the storage cylinder by a plunger and can be supplied to a hypodermic needle.
Known injection devices are suitable for the injection of liquid or pasty medicinal substance formulations, the dose being adjustable or can be fixed by the construction. In each case disclosed lengths of the hypodermic needles are suitable for intramuscular or intravenous injection. As opposed to this, the present invention proposes a planned injection of the substance formulation in specific skin layers directly below the skin surface of the animal.
Antiparasitic substances are administered either orally/intramuscularly to animals, or are applied externally to the skin. Externally applied, antiparasitic substances can diffuse through the skin layers of the animal and are subsequently systemically distributed within the animal, provided that they have a relatively low molecular weight, are sufficiently lypophilic and are applied in a formulation with permeation-increasing substances, such as e.g. 2-dimethyl sulphoxide, 2-pyrrolidone, ethanol, urea, etc. as absorption providing agents.
A disadvantage of external application is that the antiparasitic substance must be formulated with a large proportion of absorption providing agent in order to render the diffusion barrier of the skin permeable for the active substance.
As a result the natural skin function is destroyed. In addition, in the case of external application, the formulation must be used in excess, because only a proportion of the antiparasitic substance applied actually diffuses through the skin and the remaining part is passed into the environment as a pollutant without having any effect on the animal.
The essential factors influencing the proportion of the applied, antiparasitic formulation diffusing into the skin layer are the specific state of the treated skin region, i.e. the specific characteristics of a particular body area, the age and moistness of the skin and the individually differing characteristics of the skin. It is therefore difficult to estimate for a particular animal the quantity of the antiparasitic formulation necessary for obtaining the appropriately absorbed dose of the antiparasitic substance.
In view of this prior art, the present invention provides an apparatus enabling an antiparasitic substance to be administered to an animal in a reliably constant or adjustable dosage.
According to an aspect of the present invention, there is provided a combination consisting of a device for the injection of an active substance formulation into domestic animals and an active substance formulation having an antiparasitically active substance in a formulation suitable for injection, wherein the device is an injection device comprising an injection needle adapted for penetration through the outer epidermis of skin and is positioned between the outer epidermis and the lower layer of the skin above subcutaneous fat and muscle tissue and wherein the antiparasitic active substance is selected from the group consisting of IGR
chitin synthesis inhibitors, phosphoric acid esters, carbamates, pyrethrum and pyrethoids, avermectine, benzimidazoles, phenothiazines or praziquantel.
The solution provided by the invention is to offer a combination of an injection device with an antiparasitic substance in a formulation suitable for injection.
In a particularly preferred manner the injection device is of the pin type and the delivered active substance formulation quantity can be dosed. It is also important for the present invention that the penetration depth of the hypodermic needle in the injection device is dimensioned in such a way that the active substance formulation is only injected directly below the top skin layers and reaches the lower skin regions, but is not injected into the subcutaneous adipose or muscle tissue. Thus, as a possible embodiment are suitable injection devices of the pin type, in which the available hypodermic needle length only projects from the pin casing by three, preferably two and in particularly preferred manner 1 mm, so that the hypodermic needle penetration depth is predetermined by the actual apparatus.
The antiparasitic substance formulation suitable for injection preferably only contains a small proportion or adjuvants, such as e.g. resorption providers, so that even a small amount of antiparasitic formulation is adequate for administering an adequate antiparasitic agent dose. Preference is given to antiparasitic formulations, in which the antiparasitic agent is suitable for injection into an animal and which is also contained in a small formulation volume. Particular preference is given to formulations, where there is an adequate antiparasitic agent dose necessary per kilogram of animal weight in a volume of 100, preferably 50 and in particularly preferred manner 10 pI.
The dosage of the antiparasitic formulation can be performed with the apparatus combination of the invention in such a way that the quantity administered per injection pulse can be adjusted to the animal weight, e.g. by a dosing device according to EP 897 728, or the constructionally fixed dosing volume of the injection device is dimensioned in such a way that it is fixed for I, 2 or preferably 5 kg of animal weight and by multiple injections of the same formulation volume, it is possible to determine the antiparasitic formulation dose.
The apparatus according to the invention, which comprises a combination of an injection device and an antiparasitic substance in a suitable formulation, is firstly characterized by a precise, reproducible dosage of the formulation, because there are no losses due to premature evaporation or inadequate absorption by the skin.
It is also possible for the apparatus according to the invention to be safely used by non-medical practioners, because the injection device only permits a limited hypodermic needle penetration depth, so that there is only a very limited injury risk for the animal.
The antiparasitic substance formulation suitable for injection preferably only contains a small proportion or adjuvants, such as e.g. resorption providers, so that even a small amount of antiparasitic formulation is adequate for administering an adequate antiparasitic agent dose. Preference is given to antiparasitic formulations, in which the antiparasitic agent is suitable for injection into an animal and which is also contained in a small formulation volume. Particular preference is given to formulations, where there is an adequate antiparasitic agent dose necessary per kilogram of animal weight in a volume of 100, preferably 50 and in particularly preferred manner 10 pI.
The dosage of the antiparasitic formulation can be performed with the apparatus combination of the invention in such a way that the quantity administered per injection pulse can be adjusted to the animal weight, e.g. by a dosing device according to EP 897 728, or the constructionally fixed dosing volume of the injection device is dimensioned in such a way that it is fixed for I, 2 or preferably 5 kg of animal weight and by multiple injections of the same formulation volume, it is possible to determine the antiparasitic formulation dose.
The apparatus according to the invention, which comprises a combination of an injection device and an antiparasitic substance in a suitable formulation, is firstly characterized by a precise, reproducible dosage of the formulation, because there are no losses due to premature evaporation or inadequate absorption by the skin.
It is also possible for the apparatus according to the invention to be safely used by non-medical practioners, because the injection device only permits a limited hypodermic needle penetration depth, so that there is only a very limited injury risk for the animal.
It is particularly advantageous that the present invention obviates the use of large proportions of absorption providers in the active substance formulation and therefore avoids the undesired effects thereof.
The invention also makes it possible to incorporate into the formulation antiparasitic substances which, as a result of their solubility and/or inadequate lipophilicity or high molecular weight, are unsuitable for external application and absorption through the skin.
The invention also makes it possible to inject specific formulations into the skin layers of the animal which act as a depot for the antiparasitic substance.
It is clear to the expert that there can be various combinations and subcombinations of an injection device and an antiparasitic substance formulation which lead to the apparatus according to the invention.
The invention also makes it possible to incorporate into the formulation antiparasitic substances which, as a result of their solubility and/or inadequate lipophilicity or high molecular weight, are unsuitable for external application and absorption through the skin.
The invention also makes it possible to inject specific formulations into the skin layers of the animal which act as a depot for the antiparasitic substance.
It is clear to the expert that there can be various combinations and subcombinations of an injection device and an antiparasitic substance formulation which lead to the apparatus according to the invention.
Claims (6)
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A combination comprising:
(a) an antiparasitic active substance in a formulation suitable for injection, wherein said antiparasitic active substance is selected from the group consisting of IGR
chitin synthesis inhibitors, phosphoric acid esters, carbamates, pyrethrum and pyrethoids, avermectine, benzimidazoles, phenothiazines and praziquantel; and (b) an injection device for injecting said antiparasitic active substance into domestic animals, said injection device having a needle of predetermined length for facilitating injection of said antiparasitic active substance at a position between the outer epidermis and the lower layer of the skin above subcutaneous fat and muscle tissue.
(a) an antiparasitic active substance in a formulation suitable for injection, wherein said antiparasitic active substance is selected from the group consisting of IGR
chitin synthesis inhibitors, phosphoric acid esters, carbamates, pyrethrum and pyrethoids, avermectine, benzimidazoles, phenothiazines and praziquantel; and (b) an injection device for injecting said antiparasitic active substance into domestic animals, said injection device having a needle of predetermined length for facilitating injection of said antiparasitic active substance at a position between the outer epidermis and the lower layer of the skin above subcutaneous fat and muscle tissue.
2. The combination according to claim 1, wherein said injection device comprises a pin casing and said needle projects from said pin casing by 3 mm.
3. The combination according to claim 1, wherein said injection device comprises a pin casing and said needle projects from said pin casing by 2 mm.
4. The combination according to claim 1, wherein said injection device comprises a pin casing and said needle projects from said pin casing by 1 mm.
5. A device according to any one of claims 1 to 4, wherein said injection device is adapted for dispensing a fixed volume of the active substance formulation.
6. A device according to any one of claims 1 to 4, wherein the injection device comprises an adjustable metering mechanism.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99123948A EP1104683B1 (en) | 1999-12-03 | 1999-12-03 | Combination comprising a device for the injection of antiparasitic agents into pet animals and an antiparasitic agent |
| EP99123948.4 | 1999-12-03 | ||
| PCT/DE2000/004316 WO2001039822A1 (en) | 1999-12-03 | 2000-12-04 | Device for injection of antiparasitic agents in pets |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2394699A1 CA2394699A1 (en) | 2001-06-07 |
| CA2394699C true CA2394699C (en) | 2008-04-08 |
Family
ID=8239516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002394699A Expired - Fee Related CA2394699C (en) | 1999-12-03 | 2000-12-04 | Device for injection of antiparasitic agents in domestic animals |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20030078541A1 (en) |
| EP (1) | EP1104683B1 (en) |
| JP (1) | JP3642758B2 (en) |
| AT (1) | ATE293468T1 (en) |
| AU (1) | AU767933B2 (en) |
| BR (1) | BR0016057A (en) |
| CA (1) | CA2394699C (en) |
| DE (2) | DE59911951D1 (en) |
| DK (1) | DK1104683T3 (en) |
| ES (1) | ES2239426T3 (en) |
| PT (1) | PT1104683E (en) |
| WO (1) | WO2001039822A1 (en) |
| ZA (1) | ZA200204355B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7658721B2 (en) * | 2004-01-16 | 2010-02-09 | Biodel Inc. | Sublingual drug delivery device |
| ES2245591B1 (en) | 2004-04-06 | 2007-04-01 | Consejo Sup. Investigaciones Cientificas | NEW PROCEDURE FOR GENERATING NON-HUMAN TRANSGENIC ANIMALS, AND THE TRANSGENIC ANIMALS SO OBTAINED. |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4894054A (en) * | 1988-06-20 | 1990-01-16 | Miskinyar Shir A | Preloaded automatic disposable syringe |
| IT1256577B (en) * | 1992-12-11 | 1995-12-11 | Ermanno Greco | DEVICE PREPARED FOR THE AUTOMATIC ADMINISTRATION OF A DRUG VIA INTRADERMIC. |
| IE68890B1 (en) * | 1993-04-08 | 1996-07-24 | Elan Med Tech | Intradermal delivery device |
| US5540665A (en) * | 1994-01-31 | 1996-07-30 | Alza Corporation | Gas driven dispensing device and gas generating engine therefor |
| US5540657A (en) * | 1994-07-15 | 1996-07-30 | Collagen Corporation | Delivery device for injectable materials |
| US5478315A (en) * | 1994-08-08 | 1995-12-26 | Brothers Family Investments, L.C. | Local anesthetic injection system |
| AU4652596A (en) * | 1995-01-09 | 1996-07-31 | Atrix Laboratories, Inc. | Liquid polymer delivery system |
| EP0836851A1 (en) * | 1996-10-21 | 1998-04-22 | Virbac S.A. | Amidine compounds for use in treating ecto or endo parasitic diseases and systemic parasite control compositions |
| US6500150B1 (en) * | 1997-06-16 | 2002-12-31 | Elan Pharma International Limited | Pre-filled drug-delivery device and method of manufacture and assembly of same |
| US5921966A (en) | 1997-08-11 | 1999-07-13 | Becton Dickinson And Company | Medication delivery pen having an improved clutch assembly |
| US5964731A (en) | 1997-10-02 | 1999-10-12 | Kovelman; Paul H. | Disposable, disabling safety needle for a syringe, pen-type injector, or the like, and method of making the same |
| CA2223659A1 (en) | 1997-12-03 | 1999-06-03 | Alain Villette | Injector for medical use |
-
1999
- 1999-12-03 PT PT99123948T patent/PT1104683E/en unknown
- 1999-12-03 DK DK99123948T patent/DK1104683T3/en active
- 1999-12-03 AT AT99123948T patent/ATE293468T1/en active
- 1999-12-03 EP EP99123948A patent/EP1104683B1/en not_active Expired - Lifetime
- 1999-12-03 ES ES99123948T patent/ES2239426T3/en not_active Expired - Lifetime
- 1999-12-03 DE DE59911951T patent/DE59911951D1/en not_active Expired - Lifetime
-
2000
- 2000-12-04 JP JP2001541552A patent/JP3642758B2/en not_active Expired - Fee Related
- 2000-12-04 WO PCT/DE2000/004316 patent/WO2001039822A1/en not_active Ceased
- 2000-12-04 AU AU28277/01A patent/AU767933B2/en not_active Ceased
- 2000-12-04 BR BR0016057-1A patent/BR0016057A/en not_active Application Discontinuation
- 2000-12-04 CA CA002394699A patent/CA2394699C/en not_active Expired - Fee Related
- 2000-12-04 US US10/148,698 patent/US20030078541A1/en not_active Abandoned
- 2000-12-04 DE DE10083781T patent/DE10083781D2/en not_active Ceased
-
2002
- 2002-05-30 ZA ZA200204355A patent/ZA200204355B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP3642758B2 (en) | 2005-04-27 |
| AU767933B2 (en) | 2003-11-27 |
| BR0016057A (en) | 2002-10-22 |
| AU2827701A (en) | 2001-06-12 |
| DK1104683T3 (en) | 2005-08-22 |
| ES2239426T3 (en) | 2005-09-16 |
| CA2394699A1 (en) | 2001-06-07 |
| JP2003515395A (en) | 2003-05-07 |
| PT1104683E (en) | 2005-08-31 |
| ZA200204355B (en) | 2003-08-30 |
| DE10083781D2 (en) | 2002-10-24 |
| EP1104683B1 (en) | 2005-04-20 |
| ATE293468T1 (en) | 2005-05-15 |
| WO2001039822A1 (en) | 2001-06-07 |
| EP1104683A1 (en) | 2001-06-06 |
| US20030078541A1 (en) | 2003-04-24 |
| DE59911951D1 (en) | 2005-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6457383B2 (en) | Needle-assisted jet injection of testosterone composition | |
| US4451253A (en) | Means and method for administering medicinals | |
| US20020042589A1 (en) | Medical injection device | |
| US20080015522A1 (en) | Dual Chamber Injector Integrated With Micro-Needles | |
| BR0112313A (en) | Method for direct distribution of a substance, method for the administration of a pharmaceutical substance, method for distribution of a bioactive substance and micro needle for intradermal injection of a pharmaceutical substance | |
| ATE441445T1 (en) | MEDICAL SYRINGE WITH TIMER | |
| WO2003047663A3 (en) | Automatic injector | |
| BR0108379A (en) | Controlled release compositions containing opioid agonist and antagonist, method for preparing a controlled release opioid analgesic formulation with increased analgesic potency and delivery system through the dermis for an opioid analgesic | |
| JP2006522822A (en) | Alcohol-free transdermal insulin composition and process and use thereof | |
| CA2439120A1 (en) | Erodible polymers for injection | |
| Kumar | Needle free injection systems | |
| DE60130582D1 (en) | PRE-FILLED INTRADERMAL ADMINISTRATION DEVICE | |
| JP2011517311A (en) | Anesthetic composition, formulation and method of use | |
| CA2394699C (en) | Device for injection of antiparasitic agents in domestic animals | |
| ES2978587T3 (en) | Hematocrit modulation by needle-assisted jet injection of testosterone | |
| US20080299060A1 (en) | Pharmaceutical Composition for the Treatment of Nail Diseases | |
| CZ389498A3 (en) | Local anaesthetic with buffer composition for preventing rise of inflammation | |
| Seyam et al. | Evaluation of a no-needle penile injector: a preliminary study evaluating tissue penetration and its hemodynamic consequences in the rat | |
| Kumar et al. | Needle free injection systems | |
| TH82739A (en) | Self-help contraception | |
| RU2342156C2 (en) | Method for vaccine injection | |
| KR200357603Y1 (en) | Syringe needle for Mezotheraphy | |
| KR20150119041A (en) | Methods and systems for buffering anesthetic solutions with controlled pH and tonicity | |
| KR20040039612A (en) | Injector | |
| JP2547726C (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20141204 |